BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $12,885,000 | -6.0% | 160,170 | -5.7% | 0.07% | +7.6% |
Q2 2021 | $13,714,000 | -6.7% | 169,827 | -2.2% | 0.07% | -9.6% |
Q1 2021 | $14,704,000 | -5.9% | 173,698 | -12.0% | 0.07% | -13.1% |
Q4 2020 | $15,632,000 | +2.1% | 197,385 | +1.9% | 0.08% | -7.7% |
Q3 2020 | $15,314,000 | -4.4% | 193,622 | +1.8% | 0.09% | -9.9% |
Q2 2020 | $16,013,000 | +23.5% | 190,108 | +20.6% | 0.10% | +5.2% |
Q1 2020 | $12,961,000 | -19.9% | 157,685 | -18.7% | 0.10% | +7.9% |
Q4 2019 | $16,188,000 | -27.0% | 194,023 | -24.8% | 0.09% | -28.2% |
Q3 2019 | $22,170,000 | +18.2% | 258,004 | +12.4% | 0.12% | +19.2% |
Q2 2019 | $18,752,000 | +12.1% | 229,632 | +9.4% | 0.10% | +9.5% |
Q1 2019 | $16,732,000 | +15.4% | 209,982 | -5.6% | 0.10% | +3.3% |
Q4 2018 | $14,504,000 | -25.4% | 222,434 | -12.3% | 0.09% | -13.2% |
Q3 2018 | $19,434,000 | -1.6% | 253,699 | -5.1% | 0.11% | -2.8% |
Q2 2018 | $19,749,000 | +17.3% | 267,439 | +1.5% | 0.11% | +14.7% |
Q1 2018 | $16,830,000 | -2.0% | 263,600 | -0.8% | 0.10% | +3.3% |
Q4 2017 | $17,175,000 | +0.1% | 265,710 | -2.9% | 0.09% | -5.2% |
Q3 2017 | $17,165,000 | -3.8% | 273,558 | -7.8% | 0.10% | -8.5% |
Q2 2017 | $17,846,000 | +18.2% | 296,626 | +2.7% | 0.11% | +17.8% |
Q1 2017 | $15,093,000 | -9.2% | 288,810 | -23.1% | 0.09% | -10.9% |
Q4 2016 | $16,624,000 | -25.5% | 375,622 | -21.0% | 0.10% | -26.3% |
Q3 2016 | $22,313,000 | +45.3% | 475,558 | +38.8% | 0.14% | +34.3% |
Q2 2016 | $15,356,000 | +50.5% | 342,597 | +38.5% | 0.10% | +50.0% |
Q1 2016 | $10,206,000 | +4.1% | 247,358 | -4.0% | 0.07% | +1.5% |
Q4 2015 | $9,802,000 | +32.5% | 257,573 | +13.8% | 0.07% | +24.1% |
Q3 2015 | $7,397,000 | -64.6% | 226,292 | -23.5% | 0.05% | -60.3% |
Q2 2015 | $20,904,000 | +1.8% | 295,872 | -0.9% | 0.14% | +8.8% |
Q1 2015 | $20,533,000 | -1.0% | 298,654 | +6.6% | 0.12% | -1.6% |
Q4 2014 | $20,730,000 | +41.9% | 280,054 | +37.8% | 0.13% | +38.0% |
Q3 2014 | $14,606,000 | -7.5% | 203,204 | -6.2% | 0.09% | -6.1% |
Q2 2014 | $15,784,000 | -6.0% | 216,715 | -6.0% | 0.10% | -13.3% |
Q1 2014 | $16,795,000 | -34.9% | 230,519 | -38.1% | 0.11% | -37.6% |
Q4 2013 | $25,802,000 | -11.1% | 372,610 | -14.8% | 0.18% | -18.8% |
Q3 2013 | $29,027,000 | -13.1% | 437,283 | -8.8% | 0.22% | -13.9% |
Q2 2013 | $33,415,000 | – | 479,411 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |